Glow-in-the-Dark dye helps surgeons spot hidden cancer cells
NCT ID NCT05945875
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 24 times
Summary
This early-phase trial tests whether combining two imaging techniques—a radioactive tracer and a fluorescent dye—can help surgeons see and remove head and neck cancer more completely. About 40 adults with head and neck cancer will receive both imaging agents before and during surgery. The goal is to see if this approach is safe and improves detection of leftover cancer cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University/Ingram Cancer Center
RECRUITINGNashville, Tennessee, 37203, United States
Contact
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.